The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results.
The C3H/HeJ inbred mouse strain and the Dundee Experimental Bald Rat (DEBR) strain spontaneously develop adult onset alopecia areata (AA), a cell-mediated disease directed against actively growing hair follicles. The low frequency of AA and the inability to predict the stage of AA as it evolves in the naturally occuring C3H/HeJ model of AA can be converted into a highly predictable system by grafting full thickness skin from AA-affected mice to normal haired mice of the same strain. The rat DEBR model develops spontaneous AA at a higher frequency than in the mouse model but they are more expensive to use in drug studies owing to their larger size. Regardless of the shortcomings of either model, these rodent models can be used succesfully to screen novel or approved drugs for efficacy to treat human AA. As the pathogenesis of AA follows the canonical lymphocytic co-stimulatory cascade in the mouse AA model, it can be used to screen compounds potentially useful to treat a variety of cell-mediated diseases. Efficacy of various agents can easily be screened by simply observing the presence, rate, and cosmetic acceptability of hair regrowth. More sophisticated assays can refine how the drugs induce hair regrowth and evaluate the underlying pathogenesis of AA. Some drugs commonly used to treat human AA patients work equally as well in both rodent models validating their usefulness as models for drug efficacy and safety for humanAA.
Sun
Jing
J
The Jackson Laboratory, Bar Harbor, ME 04609-1500, USA.
Silva
Kathleen A
KA
McElwee
Kevin J
KJ
King
Lloyd E
LE
Sundberg
John P
JP
D000506:Alopecia Areata / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D000818:Animals; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical / Q000379:methods; D051379:Mice; D008809:Mice, Inbred C3H; D051381:Rats; D011922:Rats, Mutant Strains
J Invest Dermatol. 2004 Aug;123(2):294-7
15245428
J Invest Dermatol. 2002 Aug;119(2):392-402
12190862
Exp Dermatol. 2003 Feb;12(1):30-6
12631244
JAMA. 1975 Jul 21;233(3):249-52
1173832
J Invest Dermatol. 1989 May;92(5):689-94
2523942
Arch Dermatol Res. 1996 Mar;288(3):153-6
8967784
J Invest Dermatol. 1994 Jun;102(6):847-56
8006447
J Investig Dermatol Symp Proc. 1999 Dec;4(3):239
10674374
Biochem Pharmacol. 1997 May 9;53(9):1215-21
9214681
Immunology. 1991 Apr;72(4):563-70
2037316
J Invest Dermatol. 1994 Aug;103(2):143-7
8040602
Clin Exp Dermatol. 1995 Mar;20(2):127-31
8565246
East Afr Med J. 1994 Oct;71(10):674-5
7821250
Eur J Immunol. 2001 May;31(5):1582-91
11465116
Int J Dermatol. 1984 Nov;23(9):624-6
6519874
J Am Acad Dermatol. 1990 Feb;22(2 Pt 1):242-50
2138175
Clin Exp Dermatol. 2002 Jul;27(5):410-7
12190642
Dermatol Clin. 1998 Apr;16(2):341-56
9589208
J Invest Dermatol. 2003 Mar;120(3):400-6
12603852
Curr Pharm Des. 2001 Feb;7(3):213-30
11311114
BMC Dermatol. 2005 May 26;5:6
15918897
Br J Dermatol. 1996 Jan;134(1):55-63
8745887
J Invest Dermatol. 1998 Nov;111(5):797-803
9804341
J Invest Dermatol. 1998 Jul;111(1):175
9665409
J Investig Dermatol Symp Proc. 2003 Jun;8(1):6-11
12894987
Dermatologica. 1984;168(5):224-9
6724078
J Exp Med. 1990 Apr 1;171(4):1315-32
2139102
Acta Derm Venereol. 1996 Jan;76(1):17-20
8721483
Exp Dermatol. 2006 Jul;15(7):515-22
16761960
Mayo Clin Proc. 1995 Jul;70(7):628-33
7791384
J Dermatol Sci. 1994 Jul;7 Suppl:S47-54
7528050
N Engl J Med. 1980 Dec 18;303(25):1480-1
7432414
J Invest Dermatol. 1997 Sep;109(3):329-33
9284100
Am J Hum Genet. 2007 Feb;80(2):316-28
17236136
Am J Pathol. 2008 Mar;172(3):650-8
18245811
Arch Dermatol. 1999 Nov;135(11):1349-53
10566833
J Investig Dermatol Symp Proc. 2003 Oct;8(2):222-5
14582679
Dermatol Nurs. 2004 Aug;16(4):333-6
15471045
J Invest Dermatol. 1995 May;104(5 Suppl):32S-33S
7738387
Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12525-30
8901615
Br J Dermatol. 1997 Apr;136(4):542-7
9155955
J Immunol. 1998 Feb 1;160(3):1212-8
9570536
Eur J Dermatol. 2000 Aug;10(6):443-50
10980465
J Am Acad Dermatol. 2005 Jan;52(1):138-9
15627095
J Immunol. 1997 Jan 1;158(1):446-51
8977221
Oncology. 2001;60(2):101-9
11244323
Arch Dis Child. 2000 Jun;82(6):483-7
10833183
J Invest Dermatol. 1991 May;96(5):88S-89S
2022894
Expert Rev Mol Med. 2006 Jun 20;8(14):1-19
16787552
J Invest Dermatol. 1998 Sep;111(3):464-71
9740242
Br J Dermatol. 1971 Sep;85(3):272-3
5111692
J Invest Dermatol. 2005 Jan;124(1):288-9
15654992
J Invest Dermatol. 2007 Jun;127(6):1489-97
17273166
Ann N Y Acad Sci. 1998 May 1;840:45-50
9629235
Exp Dermatol. 2004 Jan;13(1):5-10
15009110
Am J Cardiol. 1973 Mar;31(3):355-61
4687850
Int J Pharm. 2005 Dec 8;306(1-2):91-8
16253450
J Clin Invest. 1998 Jan 1;101(1):62-7
9421466
Eur J Dermatol. 2004 Sep-Oct;14(5):332-8
15358573
Int J Tissue React. 2005;27(3):107-10
16372476
Br J Dermatol. 1996 Dec;135(6):942-8
8977716
Exp Dermatol. 2001 Dec;10(6):420-9
11737261
Semin Hematol. 1999 Jul;36(3):282-9
10462328
J Invest Dermatol. 2005 May;124(5):947-57
15854035
Eur Ann Allergy Clin Immunol. 2003 Dec;35(10):397-401
14768526
J Investig Dermatol Symp Proc. 1999 Dec;4(3):202-6
10674366
Br J Dermatol. 1996 Oct;135(4):581-5
8915150
Pathobiology. 1998;66(2):90-107
9645633
J Investig Dermatol Symp Proc. 2003 Oct;8(2):182-7
14582670
J Invest Dermatol. 2000 Oct;115(4):653-7
10998138
J Investig Dermatol Symp Proc. 2003 Jun;8(1):87-90
12895001
J Cell Physiol. 1997 Jun;171(3):305-17
9180900
Immunol Lett. 1991 Aug;29(3):191-6
1769706
Lab Invest. 1987 Jun;56(6):684-6
3599911
Dermatol Clin. 1996 Oct;14(4):739-44
9238332
Cell. 2008 Jan 25;132(2):299-310
18243104
J Am Acad Dermatol. 1997 Jan;36(1):114-7
8996277
Arch Dermatol. 2001 Aug;137(8):1063-8
11493099
Pharmacol Toxicol. 2000 Apr;86(4):169-77
10815750
Yale J Biol Med. 1993 Nov-Dec;66(6):541-54
7716973
J Investig Dermatol Symp Proc. 1999 Dec;4(3):211-5
10674368
J Am Acad Dermatol. 1987 Mar;16(3 Pt 2):657-68
3558911
J Invest Dermatol. 1997 Apr;108(4):412-22
9077468
Dermatology. 1992;184(3):198-201
1392112
J Investig Dermatol Symp Proc. 2003 Oct;8(2):212-6
14582676
J Immunol. 1995 Aug 1;155(3):1151-64
7636184
Dermatology. 1998;196(4):418-21
9669118
Mutat Res. 1980 May;70(3):269-78
6991915
J Invest Dermatol. 1999 Jul;113(1):61-8
10417620
Arch Dermatol Res. 1980;267(1):109-14
6446265
J Am Acad Dermatol. 2003 Dec;49(6):1013-9
14639378
J Invest Dermatol. 2002 Jun;118(6):983-92
12060392
J Investig Dermatol Symp Proc. 1999 Dec;4(3):207-10
10674367
J Am Acad Dermatol. 1993 Nov;29(5 Pt 1):729-35
7901248
J Immunol. 1989 Sep 1;143(5):1560-4
2788187
Skin Therapy Lett. 2000;5(5):3-4
10854342
Eur J Dermatol. 2001 Sep-Oct;11(5):405-9
11525945
Br J Dermatol. 1973 Jan;88(1):55-9
4686543
Int J Dermatol. 1997 Apr;36(4):320
9169343
Br J Dermatol. 1997 Oct;137(4):491-7
9390322
Br J Dermatol. 1991 Aug;125(2):94-100
1911310
J Am Acad Dermatol. 1984 Aug;11(2 Pt 1):216-23
6384283
Am J Physiol Endocrinol Metab. 2000 Feb;278(2):E202-10
10662703
J Am Acad Dermatol. 1986 Jun;14(6):1089-90
3487558
Immunol Lett. 1993 Apr;36(1):1-6
8102123
Arch Dermatol. 1963 Sep;88:290-7
14043621